BMS-986278 is a potent, orally bioavailable antagonist of the lysophosphatidic acid receptor 1 (LPA1), demonstrating high affinity for both human and mouse targets. It is a research compound under investigation for fibrotic diseases, including idiopathic pulmonary fibrosis, with studies conducted in relevant cellular and animal models.